Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [18F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma.
Henriksen OM, Hansen AE, Muhic A, Marner L, Madsen K, Møller S, Hasselbalch B, Lundemann MJ, Scheie D, Skjøth-Rasmussen J, Poulsen HS, Larsen VA, Larsson HBW, Law I. Henriksen OM, et al. Among authors: muhic a. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4677-4691. doi: 10.1007/s00259-022-05917-3. Epub 2022 Jul 30. Eur J Nucl Med Mol Imaging. 2022. PMID: 35907033 Free PMC article.
Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.
Hofland KF, Hansen S, Sorensen M, Engelholm S, Schultz HP, Muhic A, Grunnet K, Ask A, Costa JC, Kristiansen C, Thomsen C, Poulsen HS, Lassen U. Hofland KF, et al. Among authors: muhic a. Acta Oncol. 2014 Jul;53(7):939-44. doi: 10.3109/0284186X.2013.879607. Epub 2014 Jan 23. Acta Oncol. 2014. PMID: 24456504 Clinical Trial.
Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.
Galldiks N, Dunkl V, Ceccon G, Tscherpel C, Stoffels G, Law I, Henriksen OM, Muhic A, Poulsen HS, Steger J, Bauer EK, Lohmann P, Schmidt M, Shah NJ, Fink GR, Langen KJ. Galldiks N, et al. Among authors: muhic a. Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2377-2386. doi: 10.1007/s00259-018-4082-4. Epub 2018 Jul 7. Eur J Nucl Med Mol Imaging. 2018. PMID: 29982845 Clinical Trial.
Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma.
Lundemann M, Munck Af Rosenschöld P, Muhic A, Larsen VA, Poulsen HS, Engelholm SA, Andersen FL, Kjær A, Larsson HBW, Law I, Hansen AE. Lundemann M, et al. Among authors: muhic a. Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):603-613. doi: 10.1007/s00259-018-4180-3. Epub 2018 Oct 2. Eur J Nucl Med Mol Imaging. 2019. PMID: 30276440 Clinical Trial.
34 results